149 related articles for article (PubMed ID: 3495649)
1. Synthesis and evaluation of fluorine-18 21-fluoroprednisone as a potential ligand for neuro-PET studies.
Feliu AL; Rottenberg DA
J Nucl Med; 1987 Jun; 28(6):998-1005. PubMed ID: 3495649
[TBL] [Abstract][Full Text] [Related]
2. Syntheses and specific activity determinations of no-carrier-added (NCA) F-18-labeled butyrophenone neuroleptics--benperidol, haloperidol, spiroperidol, and pipamperone.
Shiue CY; Fowler JS; Wolf AP; Watanabe M; Arnett CD
J Nucl Med; 1985 Feb; 26(2):181-6. PubMed ID: 2857191
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of structurally identical fluorine-18 and iodine isotope labeling compounds for comparative imaging.
Li Z; Ding YS; Gifford A; Fowler JS; Gatley JS
Bioconjug Chem; 2003; 14(2):287-94. PubMed ID: 12643738
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of [11C]hemicholinium-15 and [18F]hemicholinium-15 as new potential PET tracers for the high-affinity choline uptake system in the heart.
Gao M; Miller MA; DeGrado TR; Mock BH; Lopshire JC; Rosenberger JG; Dusa C; Das MK; Groh WJ; Zipes DP; Hutchins GD; Zheng QH
Bioorg Med Chem; 2007 Feb; 15(3):1289-97. PubMed ID: 17116396
[TBL] [Abstract][Full Text] [Related]
5. Fluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats.
Lemaire C; Cantineau R; Guillaume M; Plenevaux A; Christiaens L
J Nucl Med; 1991 Dec; 32(12):2266-72. PubMed ID: 1744713
[TBL] [Abstract][Full Text] [Related]
6. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vivo evaluation of fluorine-18 and iodine-123 labeled 2beta-carbo(2-fluoroethoxy)-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane as a candidate serotonin transporter imaging agent.
Plisson C; Stehouwer JS; Voll RJ; Howell L; Votaw JR; Owens MJ; Goodman MM
J Med Chem; 2007 Sep; 50(19):4553-60. PubMed ID: 17705359
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 4-(5-[18F]fluoromethyl-3-phenylisoxazol-4-yl)benzenesulfonamide, a new [18F]fluorinated analogue of valdecoxib, as a potential radiotracer for imaging cyclooxygenase-2 with positron emission tomography.
Toyokuni T; Kumar JS; Walsh JC; Shapiro A; Talley JJ; Phelps ME; Herschman HR; Barrio JR; Satyamurthy N
Bioorg Med Chem Lett; 2005 Nov; 15(21):4699-702. PubMed ID: 16153836
[TBL] [Abstract][Full Text] [Related]
9. Enantioselective synthesis of 6-[fluorine-18]-fluoro-L-dopa from no-carrier-added fluorine-18-fluoride.
Lemaire C; Damhaut P; Plenevaux A; Comar D
J Nucl Med; 1994 Dec; 35(12):1996-2002. PubMed ID: 7989984
[TBL] [Abstract][Full Text] [Related]
10. Development of fluorine-18-labeled 5-HT1A antagonists.
Lang L; Jagoda E; Schmall B; Vuong BK; Adams HR; Nelson DL; Carson RE; Eckelman WC
J Med Chem; 1999 May; 42(9):1576-86. PubMed ID: 10229627
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, radiolabeling, in vitro and in vivo evaluation of [18F]-FPECMO as a positron emission tomography radioligand for imaging the metabotropic glutamate receptor subtype 5.
Lucatelli C; Honer M; Salazar JF; Ross TL; Schubiger PA; Ametamey SM
Nucl Med Biol; 2009 Aug; 36(6):613-22. PubMed ID: 19647167
[TBL] [Abstract][Full Text] [Related]
12. Fluorine-18 labeling of proteins.
Kilbourn MR; Dence CS; Welch MJ; Mathias CJ
J Nucl Med; 1987 Apr; 28(4):462-70. PubMed ID: 3494825
[TBL] [Abstract][Full Text] [Related]
13. Fluorine-18 labeling of phosphopeptides: a potential approach for the evaluation of phosphopeptide metabolism in vivo.
Richter S; Bergmann R; Pietzsch J; Ramenda T; Steinbach J; Wuest F
Biopolymers; 2009; 92(6):479-88. PubMed ID: 19521975
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of a new [18F]fluoropyridine-based haloacetamide reagent for the labeling of oligonucleotides: 2-bromo-N-[3-(2-[18F]fluoropyridin-3-yloxy)propyl]acetamide.
Kuhnast B; de Bruin B; Hinnen F; Tavitian B; Dollé F
Bioconjug Chem; 2004; 15(3):617-27. PubMed ID: 15149190
[TBL] [Abstract][Full Text] [Related]
15. High yield synthesis of 6-[18F]fluoro-L-dopa by regioselective fluorination of protected L-dopa with [18F]acetylhypofluorite.
Chaly T; Diksic M
J Nucl Med; 1986 Dec; 27(12):1896-901. PubMed ID: 3097278
[TBL] [Abstract][Full Text] [Related]
16. No-carrier-added (NCA) (+/-)-N-(3-[18F]fluoropropyl)-N-normetazocine-synthesis and PET studies in a baboon.
Shiue CY; Teng RR; Bai LQ; Wolf AP; Arnett CD; Simon EJ
Int J Rad Appl Instrum B; 1987; 14(2):119-22. PubMed ID: 3496324
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and organ distribution of [18F]fluoro-Org 6141 in the rat: a potential glucocorticoid receptor ligand for positron emission tomography.
Visser GM; Krugers HJ; Luurtsema G; van Waarde A; Elsinga PH; deKloet ER; Groen MB; Bohus B; Go KG; Paans AM
Nucl Med Biol; 1995 Oct; 22(7):915-20. PubMed ID: 8547889
[TBL] [Abstract][Full Text] [Related]
18. Application of robotics to radiopharmaceutical preparation: controlled synthesis of fluorine-18 16 alpha-fluoroestradiol-17 beta.
Brodack JW; Kilbourn MR; Welch MJ; Katzenellenbogen JA
J Nucl Med; 1986 May; 27(5):714-21. PubMed ID: 3486960
[TBL] [Abstract][Full Text] [Related]
19. Fluorine-18-N-methylspiroperidol: radiolytic decomposition as a consequence of high specific activity and high dose levels.
MacGregor RR; Schlyer DJ; Fowler JS; Wolf AP; Shiue CY
J Nucl Med; 1987 Jan; 28(1):60-7. PubMed ID: 3491887
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, tissue distribution in rats and PET studies in baboon brain of no-carrier-added [18F]RU 52461: in vivo evaluation as a brain glucocorticoid receptor radioligand.
Dasilva JN; Crouzel C; Stulzaft O; Khalili-Varasteh M; Hantraye P
Int J Rad Appl Instrum B; 1992 Feb; 19(2):167-73. PubMed ID: 1601670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
